BIOMAT Database Logo BIOMAT Database Logo

A high-throughput assay for the identification of drugs against late-stage Plasmodium falciparum gametocytes. 2011

Christopher L Peatey, and Timothy P Spicer, and Peter S Hodder, and Katharine R Trenholme, and Donald L Gardiner
Malaria Biology Laboratory, Queensland Institute of Medical Research, 300 Herston Rd., Herston, Brisbane, Australia.

Recent success in the global reduction campaign against malaria has resulted in the possibility that it may be feasible to drastically reduce or even eradicate malaria even without the introduction of a vaccine. However, while there has been significant effort to design the next generation of antimalarial drugs, one area that is underrepresented in the current antimalarial pharmacopeia is that of transmission blocking drugs directed at late-stage gametocytes. Here we describe the development of a robust and simple assay that is amenable to a high throughput format for the discovery of new antigametocyte drugs.

UI MeSH Term Description Entries
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D016778 Malaria, Falciparum Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations. Plasmodium falciparum Malaria,Malaria, Plasmodium falciparum
D021261 Parasitic Sensitivity Tests Tests that demonstrate the relative effectiveness of chemotherapeutic agents against specific parasites. Drug Sensitivity Tests, Helminth,Drug Sensitivity Tests, Parasitic,Drug Sensitivity Tests, Protozoal,Helminth Drug Sensitivity Tests,Parasite Sensitivity Tests,Protozoa Drug Sensitivity Tests,Protozoal Drug Sensitivity Tests,Parasite Sensitivity Test,Parasitic Sensitivity Test,Sensitivity Test, Parasite,Sensitivity Test, Parasitic,Sensitivity Tests, Parasite,Test, Parasite Sensitivity,Test, Parasitic Sensitivity,Tests, Parasite Sensitivity,Tests, Parasitic Sensitivity

Related Publications

Christopher L Peatey, and Timothy P Spicer, and Peter S Hodder, and Katharine R Trenholme, and Donald L Gardiner
Identification of MMV malaria box inhibitors of plasmodium falciparum early-stage gametocytes using a luciferase-based high-throughput assay.
December 2013, Antimicrobial agents and chemotherapy,
Christopher L Peatey, and Timothy P Spicer, and Peter S Hodder, and Katharine R Trenholme, and Donald L Gardiner
Luciferase-Based, High-Throughput Assay for Screening and Profiling Transmission-Blocking Compounds against Plasmodium falciparum Gametocytes.
April 2016, Antimicrobial agents and chemotherapy,
Christopher L Peatey, and Timothy P Spicer, and Peter S Hodder, and Katharine R Trenholme, and Donald L Gardiner
Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes?
February 2012, Malaria journal,
Christopher L Peatey, and Timothy P Spicer, and Peter S Hodder, and Katharine R Trenholme, and Donald L Gardiner
Effect of fluorescent dyes on in vitro-differentiated, late-stage Plasmodium falciparum gametocytes.
December 2014, Antimicrobial agents and chemotherapy,
Christopher L Peatey, and Timothy P Spicer, and Peter S Hodder, and Katharine R Trenholme, and Donald L Gardiner
Effect of antimalarial drugs on Plasmodium falciparum gametocytes.
November 2009, The Journal of infectious diseases,
Christopher L Peatey, and Timothy P Spicer, and Peter S Hodder, and Katharine R Trenholme, and Donald L Gardiner
The need to compare: assessing the level of agreement of three high-throughput assays against Plasmodium falciparum mature gametocytes.
April 2017, Scientific reports,
Christopher L Peatey, and Timothy P Spicer, and Peter S Hodder, and Katharine R Trenholme, and Donald L Gardiner
High-throughput Plasmodium falciparum growth assay for malaria drug discovery.
February 2007, Antimicrobial agents and chemotherapy,
Christopher L Peatey, and Timothy P Spicer, and Peter S Hodder, and Katharine R Trenholme, and Donald L Gardiner
Gametocyte-specific and all-blood-stage transmission-blocking chemotypes discovered from high throughput screening on Plasmodium falciparum gametocytes.
June 2022, Communications biology,
Christopher L Peatey, and Timothy P Spicer, and Peter S Hodder, and Katharine R Trenholme, and Donald L Gardiner
Naturally acquired immunity against immature Plasmodium falciparum gametocytes.
June 2019, Science translational medicine,
Christopher L Peatey, and Timothy P Spicer, and Peter S Hodder, and Katharine R Trenholme, and Donald L Gardiner
Identification of telomerase activity in gametocytes of Plasmodium falciparum.
September 2003, Biochemical and biophysical research communications,
Copied contents to your clipboard!